000			02990nam a22003017a 4500
003			ZW-GwMSU
005			20241004080433.0
008			241002b |||||||| |||| 00| 0 eng d
020			_a9781394168156 _q(paperback)
040			_arda _bEnglish _erda _cMSULIB
050	0	0	_aRC633.H63 HOF
100	1		_aHoffbrand, A. V., _eauthor.
245	1	0	_aHoffbrand's essential haematology / _ccreated by A. Victor Hoffbrand ; contributing authors, Pratima Chowdary, Graham Collins, Justin Loke.
250			_aNinth edition.
264		1	_aHoboken, NJ : _bWiley-Blackwell _c2024.
300			_a490 pages : _billustrations ; _c29 cm
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
504			_aIncludes bibliographical references and index.
505	0		_aHaemopoiesis -- Erythropoiesis and general aspects of anaemia -- Hypochromic anaemias -- Iron overload -- Megaloblastic anaemias and other macrocytic anaemias -- Haemolytic anaemias -- Genetic disorders of haemoglobin -- The white cells, part 1 : granulocytes, monocytes and their benign disorders -- The white cells, part 2 : lymphocytes and their benign disorders -- The Spleen -- The aetiology and genetics of haematological neoplasia -- Management of haematological malignancy -- Acute myeloid leukaemia -- Chronic myeloid leukaemia -- Myeloproliferative neoplasms -- Myelodysplastic neoplasias -- Acute lymphoblastic leukaemia -- The chronic lymphocytic leukaemias -- Hodgkin Lymphoma -- Non-Hodgkin lymphomas 1: General aspects -- Non-Hodgkin lymphomas -- Multiple myeloma and related plasma cell neoplasms -- Amyloid -- Aplastic anaemia and bone marrow failure syndromes -- Haemopoietic stem cell transplantation -- Platelets, coagulation and normal haemostasis -- Bleeding disorders caused by platelet and vascular abnormalities -- Hereditary coagulation disorders -- Acquired coagulation disorders and thrombotic microangiopathies -- Thrombosis 1 : Pathogenesis and diagnosis -- Thrombosis 2 : Treatment -- Haematological changes in systemic diseases -- Blood transfusion -- Pregnancy and neonatal haematology.
520			_a"Advances in the understanding the pathogenesis of blood diseases and improvements in their treatment have continued apace in the five years since the 8th edition of HEH was published. Gene mutations are increasingly used to define and classify inherited and acquired haematological diseases, as a guide to therapy and to predict prognosis. Mutations underlying many rarer blood diseases have been identified, allowing appropriate panels of DNA probes to be established, facilitating the diagnosis of future cases. Many more drugs directed against specific sites in the cell signalling pathways have been approved"-- _cProvided by publisher.
650	1	2	_aHematologic Diseases
700	1		_aChowdary, Pratima, _eauthor.
700	1		_aCollins, Graham _c(Hematologist) _eauthor.
700	1		_aLoke, Justin, _d1984- _eauthor.
942			_2lcc _cB
999			_c167464 _d167464